Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Patricia Kringas"'
Autor:
Michael Rosenbaum, Ileana Vargas, Richard Weil, Patricia Kringas, Mary Horlick, Ilene Fennoy, Cathy Nonas
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 92:504-508
Context: Risk factors for type 2 diabetes mellitus (T2DM) include obesity, family history, dyslipidemia, a proinflammatory state, impaired insulin secretory capacity, and insulin resistance. Objective: The aim of this study was to examine the effects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::697b51a852cf036f1eda45207dd0f262
https://doi.org/10.1210/jc.2006-1516
https://doi.org/10.1210/jc.2006-1516
Autor:
Cathy Nonas, Holly Schachner, Mary Horlick, Richard Weil, Patricia Kringas, Ilene Fennoy, Kristi Stanton, Ileana Vargas, Michael Rosenbaum
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 89:5469-5476
The prevalence of type 2 diabetes mellitus (T2DM) among adolescents has increased 5- to 10-fold over the past decade. T2DM results from pancreatic beta-cell dysfunction and insulin resistance. Using rapid iv glucose tolerance testing, we examined bet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f5fbe7a8b77079c1588cbd87e9ed846
https://doi.org/10.1210/jc.2004-0971
https://doi.org/10.1210/jc.2004-0971
Autor:
Natalie Walders Abramson, Paula M. Trief, Patrice M. Yasuda, Lorraine E. Levitt Katz, Terri L Casey, Siripoom McKay, Barbara J. Anderson, Sharon L. Edelstein, Sherida E. Tollefsen, Marsha D. Marcus, Sylvia Lavietes, Patricia Kringas
Publikováno v:
Diabetes Care
OBJECTIVE The study objective was to examine the prevalence of depressive symptoms and relationships to quality of life and demographics in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study’s large, ethnically diverse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c53de47823d3f998ac0f04dbcca18b46
https://doi.org/10.2337/dc11-0431
https://doi.org/10.2337/dc11-0431
Autor:
Rudolph L. Leibel, Paul L. Harris, Robin Goland, Matthew J. Freeby, Antonella Maffei, Masanori Ichise, Patricia Kringas, Chaitan Divgi
Publikováno v:
Molecular imaging and biology (2015). doi:10.1007/s11307-015-0888-7
info:cnr-pdr/source/autori:Freeby MJ, Kringas P, Goland RS, Leibel RL, Maffei A, Divgi C, Ichise M, Harris PE./titolo:Cross-sectional and Test-Retest Characterization of PET with [18F]FP-(+)-DTBZ for ? Cell Mass Estimates in Diabetes./doi:10.1007%2Fs11307-015-0888-7/rivista:Molecular imaging and biology/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume
Molecular Imaging and Biology
info:cnr-pdr/source/autori:Freeby MJ, Kringas P, Goland RS, Leibel RL, Maffei A, Divgi C, Ichise M, Harris PE./titolo:Cross-sectional and Test-Retest Characterization of PET with [18F]FP-(+)-DTBZ for ? Cell Mass Estimates in Diabetes./doi:10.1007%2Fs11307-015-0888-7/rivista:Molecular imaging and biology/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume
Molecular Imaging and Biology
Purpose The vesicular monoamine transporter, type 2 (VMAT2) is expressed by insulin producing β cells and was evaluated as a biomarker of β cell mass (BCM) by positron emission tomography (PET) with [18F]fluoropropyl-dihydrotetrabenazine ([18F]FP-(
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a196f5a709b61244a0813124e6b6eda